Stay updated on Inhaled Cannabinoids vs Oral Opioids Clinical Trial
Sign up to get notified when there's something new on the Inhaled Cannabinoids vs Oral Opioids Clinical Trial page.

Latest updates to the Inhaled Cannabinoids vs Oral Opioids Clinical Trial page
- Check2 days agoChange DetectedThe record describes a Phase 2 crossover study comparing inhaled PPP001 with immediate-release oral opioids for breakthrough cancer pain. It provides the study design, eligibility criteria, locations, and pain-related outcome measures.SummaryDifference45%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check23 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the study page remains inaccessible with a 403 error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error. Its footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows a 403 Forbidden message with a minimal header and footer, indicating the study record is temporarily inaccessible.SummaryDifference18%

Stay in the know with updates to Inhaled Cannabinoids vs Oral Opioids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Cannabinoids vs Oral Opioids Clinical Trial page.